References
- Sturdee DW, Panay N. Recommendations for the management of postmenopausal vaginal atrophy. Climacteric 2010;13:509–22
- Bygdeman M, Swahn ML. Replens versus dienoestrol cream in the symptomatic treatment of vaginal atrophy in postmenopausal women. Maturitas 1996;23:259–63
- Nachtigall LE. Comparative study: Replens versus local estrogen. Fertil Steril 1994;61:178–80
- Biglia N, Peano E, Sgandurra P, et al. Low-dose vaginal estrogens or vaginal moisturizer in breast cancer survivors with urogenital atrophy: a preliminary study. Gynecol Endocrinol 2010;26:404–12
- Bachmann GA, Notelovitz M, Kelly SJ, Thompson C. Long term nonhormonal treatment of vaginal dryness. Clin Pract Sexuality 1992;8:3–8
- Bachmann GA, Notelovitz M, Gonzalez SJ, Thompson C, Morecraft BA. Vaginal dryness in postmenopausal women: clinical characteristics and nonhormonal treatment. Clin Pract Sexuality 1991;7:1–8
- van der Laak JAWM, de Bie LMT, de Leeuw H, de Wilde PCMHanselaar AGJM. The effect of Replens on vaginal cytology in the treatment of postmenopausal atrophy: cytomorphology versus computerised cytometry. J Clin Pathol 2002;55:446–51
- Suckling JA, Kennedy R, Lethaby A, Roberts H. Local oestrogen for vaginal atrophy in postmenopausal women. Cochrane Database of Systematic Reviews 2006, Issue 4, Art. No.:CD001500